Trial Profile
Clinical Trials Insight: 700023836
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2007
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Docetaxel
- Indications Early breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company
- 15 Jun 2007 New trial record.